Understanding re-identification risk in PPRL: key takeaways from our expert webinar
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
New research is challenging long-held assumptions about privacy-preserving record linkage (PPRL)....
Early signals indicate continued declines in influenza vaccination uptake and shifts in the...
Veterans Day invites us to look beyond branch and rank to the people and stories behind the...
In just a few years, artificial intelligence (AI) has become a trusted tool in early drug...
Digital health innovators and pharma leaders are under increasing pressure to show that new models...
(Part 2) In Part 1 we explored how HealthVerity Marketplace delivers high-quality,...
(Part 1) When clients see real-world data (RWD) in HealthVerity Marketplace, it may appear...
In this edition of our Ask an Expert series, we turn to Emery Niemiec, Principal of Government...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world evidence...